← back to search

Shuo Chen

Nanjing University · US
Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cerebrovascular and Carotid Artery Diseases, Cardiovascular Health and Disease Prevention, Lung Cancer Diagnosis and Treatment, and Culture, Economy, and Development Studies.
h-index
48
citations
10,960
works
441
NIH funding
primary concept
Medicine
email

Recent publications

Disparities of itch severity in outpatient clinics as measured by the ItchyQuant
Journal of the American Academy of Dermatology 2026cited by 0position: contributordoi
Plasma proteomic profiles identify biomarkers predicting Crohn’s disease up to 16 years before onset
Nature Communications 2025cited by 4position: middledoi
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age.
2025cited by 1position: contributordoi
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision.
2025cited by 1position: contributordoi
Electronic patient-reported outcome measures for triaging and scheduling outpatient appointments: a systematic review and meta-analysis.
2025cited by 1position: contributordoi
Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms.
2025cited by 1position: contributordoi
Racial Differences in Work Relative Value Units for Outpatient Pediatric Dermatology Visits.
2025cited by 0position: contributordoi
Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin color.
2025cited by 0position: contributordoi
Commentary on "Capture of patient itch scores in practice reveals disparate itch impact based upon age, gender and race: A cross-sectional survey analysis."
2025cited by 0position: contributordoi
Clinical Observational Study Utilizing Teledermatology in Bullous Pemphigoid.
2025cited by 0position: contributordoi
Transgender Individuals' Perspectives on Teledermatology-Based Acne Research.
2025cited by 0position: contributordoi
The rat acute oral toxicity of trifluoromethyl compounds (TFMs): a computational toxicology study combining the 2D-QSTR, read-across and consensus modeling methods
Archives of Toxicology 2024cited by 13position: middledoi
Image Quality Assessment Using Convolutional Neural Network in Clinical Skin Images.
2024cited by 5position: contributordoi
Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa.
2024cited by 5position: contributordoi
Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment.
2024cited by 4position: contributordoi
Lived Experience of Acne and Acne Treatment in Transgender Patients.
2024cited by 4position: contributordoi
Evaluation of the measurement properties and validation of the Skindex-16 among patients with acne.
2024cited by 3position: contributordoi
Burden of chronic skin disease from an Asian perspective: Assessment of health state utilities and quality of life in a Singapore cohort.
2024cited by 2position: contributordoi
ItchyQoL reveals differences in itch symptom experience in routine dermatologic care.
2024cited by 1position: contributordoi
Barriers and Facilitators to Teledermatology and Tele-Eye Care in Department of Veterans Affairs Provider Settings: Qualitative Content Analysis.
2024cited by 1position: contributordoi
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis.
2024cited by 1position: contributordoi
Supplementary Figure S5 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Table S5 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Table S3 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Table S1 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Data from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Table S2 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Table S4 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Figure S6 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi
Supplementary Figure S4 from Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024cited by 0position: contributordoi

Grants

EARS: Enabling Opportunistic Environmental Monitoring with Non-Uniform Sampling and Processing Circuits
NSF1643004$899,9982016–2021PIRePORTER
CAREER: Asynchronous Analog-to-Digital Converters with Non-Uniform Discrete-Time Signal Processing
NSF1351956$400,0002014–2020PIRePORTER

Frequent collaborators

· 35 papers (2019–2026)Kavita Y. Sarin · Emergency University15 papers (2024–2024)Emily Y. Chu · Hospital of the University of Pennsylvania15 papers (2024–2024)Gabriel J. Starrett · National Cancer Research Institute15 papers (2024–2024)Mary L. Piaskowski · University of Minnesota15 papers (2024–2024)Rama Godse · Pennsylvania Hospital15 papers (2024–2024)Isaac Brownell · National Institutes of Health15 papers (2024–2024)Kerri E. Rieger · Palo Alto University15 papers (2024–2024)Alisa M. Goldstein · Department of Health and Human Services15 papers (2024–2024)Elizabeth G. Berry · Oregon Health & Science University15 papers (2024–2024)Roberto A. Novoa · Palo Alto University15 papers (2024–2024) · 15 papers (2024–2024)Brittany C. Baikie · University of California, Davis15 papers (2024–2024)Hans Grossniklaus · Mayo Hospital15 papers (2024–2024)Eric A. Engels · Centre international de recherche sur le cancer15 papers (2024–2024)Michael R. Sargen · United States Department of Health and Human Services15 papers (2024–2024)Kelly Yu · Moderna Therapeutics (United States)15 papers (2024–2024)Benjamin K. Stoff · Emory University15 papers (2024–2024)Michael C. Royer · United States Department of Defense15 papers (2024–2024)Inga Van Buren · 15 papers (2024–2024)